Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Related PRGO
Benzinga's Top #PreMarket Losers
Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Related Articles (PRGO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters